⌘K

Home/Filings/4/0000899243-23-003522

4//SEC Filing

Waksal Harlan 4

Accession 0000899243-23-003522

CIK 0001327273other

View on SEC.gov Company Profile

Filed

Feb 1, 7:00 PM ET

Accepted

Feb 2, 5:19 PM ET

Size

5.7 KB

Accession

0000899243-23-003522

Insider Transaction Report

Form 4

Period: 2023-01-31

Lyra Therapeutics, Inc.LYRA

DirectorExecutive Chair

Transactions

Award
Stock Option
2023-01-31+200,000→ 200,000 total
Exercise: $2.85Exp: 2033-01-30→ Common Stock (200,000 underlying)

Footnotes (1)

[F1]This option vests and becomes exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following January 31, 2023.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Lyra Therapeutics, Inc.

CIK 0001327273

Entity typeother

Related Parties

1

filerCIK 0001449008

Filing Metadata

Form type: 4
Filed: Feb 1, 7:00 PM ET
Accepted: Feb 2, 5:19 PM ET
Size: 5.7 KB

View on SEC.gov